Volume 18, Issue 2, Pages (January 2017)

Slides:



Advertisements
Similar presentations
Volume 7, Issue 3, Pages (May 2014)
Advertisements

Volume 7, Issue 6, Pages (June 2014)
Volume 11, Issue 2, Pages (April 2015)
A Requirement for ZAK Kinase Activity in Canonical TGF-β Signaling
A Requirement for ZAK Kinase Activity in Canonical TGF-β Signaling
Volume 17, Issue 1, Pages (September 2016)
Volume 17, Issue 5, Pages (May 2013)
Volume 22, Issue 5, Pages (May 2012)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation  Graeme J. Gowans,
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Volume 135, Issue 5, Pages e2 (November 2008)
Volume 18, Issue 3, Pages (April 2005)
Sherilyn Grill, Valerie M. Tesmer, Jayakrishnan Nandakumar 
Ivar Ilves, Tatjana Petojevic, James J. Pesavento, Michael R. Botchan 
Volume 18, Issue 13, Pages (March 2017)
Volume 7, Issue 3, Pages (May 2014)
Volume 91, Issue 4, Pages (November 1997)
PKA phosphorylates Thr63 and Ser692 to increase HIF-1α stability.
Volume 51, Issue 2, Pages (July 2013)
Yanhui Xu, Yu Chen, Ping Zhang, Philip D. Jeffrey, Yigong Shi 
Volume 7, Issue 1, Pages (April 2014)
Volume 18, Issue 5, Pages (January 2017)
Volume 12, Issue 5, Pages (November 2003)
Volume 21, Issue 7, Pages (November 2017)
Volume 25, Issue 5, Pages (March 2007)
Volume 17, Issue 9, Pages (November 2016)
Volume 21, Issue 5, Pages (May 2014)
Volume 36, Issue 2, Pages (February 2012)
Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase  Yosuke Yoneyama, Tomomi Inamitsu, Kazuhiro Chida, Shun-Ichiro.
Volume 137, Issue 1, Pages (April 2009)
Volume 41, Issue 5, Pages e5 (June 2017)
Volume 3, Issue 1, Pages (January 2013)
Volume 23, Issue 4, Pages (April 2018)
Volume 38, Issue 5, Pages (June 2010)
Volume 25, Issue 21, Pages (November 2015)
Zain Paroo, Xuecheng Ye, She Chen, Qinghua Liu  Cell 
Volume 16, Issue 5, Pages (November 2012)
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 24, Issue 4, Pages e5 (April 2017)
Junbiao Dai, Weiwu Xie, Troy L. Brady, Jiquan Gao, Daniel F. Voytas 
Sphingolipid Signaling Mediates Iron Toxicity
Volume 39, Issue 2, Pages (July 2010)
Volume 17, Issue 6, Pages (November 2016)
Volume 17, Issue 6, Pages (June 2013)
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing
Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
Genetic and Epigenetic Strategies Potentiate Gal4 Activation to Enhance Fitness in Recently Diverged Yeast Species  Varun Sood, Jason H. Brickner  Current.
Flora Ambre Honoré, Vincent Méjean, Olivier Genest  Cell Reports 
Volume 73, Issue 3, Pages e3 (February 2019)
Volume 31, Issue 6, Pages (September 2008)
Volume 14, Issue 9, Pages (March 2016)
Vaccinia Virus F11 Promotes Viral Spread by Acting as a PDZ-Containing Scaffolding Protein to Bind Myosin-9A and Inhibit RhoA Signaling  Yutaka Handa,
Volume 28, Issue 5, Pages (December 2007)
Volume 22, Issue 2, Pages (January 2018)
An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins
Volume 13, Issue 10, Pages (December 2015)
Nitobe London, Steven Ceto, Jeffrey A. Ranish, Sue Biggins 
Volume 53, Issue 1, Pages (January 2014)
Volume 13, Issue 11, Pages (December 2015)
Feng Xu, Qiongyi Zhang, Kangling Zhang, Wei Xie, Michael Grunstein 
Structural and Mechanistic Analysis of the Slx1-Slx4 Endonuclease
Volume 68, Issue 3, Pages e5 (November 2017)
Volume 39, Issue 2, Pages (July 2010)
Enhancement of BLM-DNA2-Mediated Long-Range DNA End Resection by CtIP
Volume 87, Issue 5, Pages (November 1996)
Volume 13, Issue 8, Pages (November 2015)
Volume 10, Issue 1, Pages (January 2017)
Allosteric Regulation of NCLX by Mitochondrial Membrane Potential Links the Metabolic State and Ca2+ Signaling in Mitochondria  Marko Kostic, Tomer Katoshevski,
CDK Phosphorylation of Translation Initiation Factors Couples Protein Translation with Cell-Cycle Transition  Tai An, Yi Liu, Stéphane Gourguechon, Ching.
Nitrogen Regulates AMPK to Control TORC1 Signaling
Presentation transcript:

Volume 18, Issue 2, Pages 307-313 (January 2017) Ptc7p Dephosphorylates Select Mitochondrial Proteins to Enhance Metabolic Function  Xiao Guo, Natalie M. Niemi, Paul D. Hutchins, Samson G.F. Condon, Adam Jochem, Arne Ulbrich, Alan J. Higbee, Jason D. Russell, Alessandro Senes, Joshua J. Coon, David J. Pagliarini  Cell Reports  Volume 18, Issue 2, Pages 307-313 (January 2017) DOI: 10.1016/j.celrep.2016.12.049 Copyright © 2017 The Author(s) Terms and Conditions

Cell Reports 2017 18, 307-313DOI: (10.1016/j.celrep.2016.12.049) Copyright © 2017 The Author(s) Terms and Conditions

Figure 1 Ptc7p Phosphatase Activity Supports Respiratory Function (A) Summary table of mitochondrial phosphatases, analyzed for protein phosphatase domains, matrix localization, non-association with a protein complex (e.g., PDH), and presence of a yeast ortholog. PPTC7 (highlighted) is the only phosphatase to meet all four criteria. (B) In vitro phosphatase activity assay of Ptc7p against pNPP with divalent cations Mn2+ and Mg2+ is shown (mean ± SD, n = 3). (C) In vitro pNPP phosphatase activity assay of WT Ptc7p and two mutants predicted to disrupt metal binding (mean ± SD, n = 3). Coomassie staining (below) demonstrates comparable protein concentration and purity. (D) Maximum growth rate of WT and Δptc7 yeast in Ura− media containing 3% glycerol (G) (mean ± SD, n = 4). Rescue strains express a plasmid containing ptc7 (WT, wild-type ptc7; D109A, catalytically inactive mutant of ptc7). (E) OCR of same cultures as in (D) grown in Ura− media containing 2% dextrose (D) is shown (mean ± SD, n = 3). ∗p value < 0.05, ∗∗p value < 0.01, and ∗∗∗p value < 0.001; N.S., not significant. See also Figure S1. Cell Reports 2017 18, 307-313DOI: (10.1016/j.celrep.2016.12.049) Copyright © 2017 The Author(s) Terms and Conditions

Figure 2 Quantitative Phosphoproteomic Analysis Identifies Potential Ptc7p Substrates (A) Experimental workflow of phosphoproteomics. Peptides from three strains (WT, Δptc7, and Δptc7 + ptc7) were tagged with 8-plex TMTs for isobaric quantification. (B) Fold changes in mitochondrial phosphoisoform abundances (log2[Δptc7/WT], normalized to total protein abundance; n = 3) versus significance (−log10[p value]). Gray area indicates significance threshold (log2[Δptc7/WT] > 1 and p value < 0.05). Five highlighted phosphoisoforms are prioritized candidate Ptc7p substrates. Inset table summarizes quantified total and mitochondrial proteins or phosphoisoforms; up arrow indicates significantly increased changes and down arrow indicates significantly decreased changes. (C) Heatmap of 19 mitochondrial phosphoisoforms whose abundances were significantly increased in Δptc7 and were restored to WT level or below in the rescue strain (Δptc7 + ptc7). An asterisk denotes mitochondrial matrix phosphosites conserved in higher eukaryotes. See also Figure S2 and Tables S1 and S2. Cell Reports 2017 18, 307-313DOI: (10.1016/j.celrep.2016.12.049) Copyright © 2017 The Author(s) Terms and Conditions

Figure 3 Phosphorylation of Cit1p at S462 Disrupts Enzyme Function (A) Serial dilutions of WT and Δcit1 yeast expressing various plasmids grown on glucose- or acetate-containing Ura− plates are shown. (B) Citrate synthase activity of Δcit1 lysate expressing EV, WT, S462A, or S462E Cit1p (mean ± SD, n = 3). Statistics are relative to WT activity (lane 2). Inset shows immunoblot against FLAG (Cit1p-FLAG) or actin (loading control). (C) Kinetic curve of recombinant WT, S462A, or S462E Cit1p. Citrate synthase activity (μM/s) is plotted versus concentration of OAA (μM). Inset shows comparable loading (Coomassie staining). Table shows the calculated Vmax and Km for each Cit1p mutant. (D) Citrate synthase activity of lysate from WT or Δptc7 (mean ± SD, n = 4). Rescue strains express a plasmid containing ptc7 (WT, wild-type ptc7; D109A, catalytically inactive mutant of ptc7). (E) Citrate synthase activity of recombinant WT or phospho-S462 (pSer462) Cit1p treated with WT or D109A Ptc7p is shown (mean ± SD, n = 3). (F) Coomassie staining of a PhosTag gel loaded with the samples in (E). ∗p value < 0.05, ∗∗p value < 0.01, and ∗∗∗p value < 0.001; N.S., not significant. See also Figure S3. Cell Reports 2017 18, 307-313DOI: (10.1016/j.celrep.2016.12.049) Copyright © 2017 The Author(s) Terms and Conditions

Figure 4 Phosphorylation of Cit1p Occurs at the Dimer Interface (A–D) Structural interaction of residue 462 with L89 in the opposite chain, with residue 462 modeled as (A) S (WT), (B) A, (C) pS (phospho-serine), and (D) E (based on structure PDB: 3ENJ), is shown. (E) Energy of computed models of A, pS, and E mutants at position 462, compared to WT, with analysis of pig and chicken structures and a yeast homology model, is shown. (F) Coomassie staining of native-PAGE loaded with recombinant WT (2× biological replicates), S462A, and S462E Cit1p is shown. (G) FLAG immunoblot of native-PAGE- and SDS-PAGE-resolved lysates of Δcit1 expressing EV or C-terminal FLAG-tagged WT, S462A, or S462E Cit1p is shown. See also Figure S4. Cell Reports 2017 18, 307-313DOI: (10.1016/j.celrep.2016.12.049) Copyright © 2017 The Author(s) Terms and Conditions